论文部分内容阅读
2003年公司理顺营销体系后,各系列酒产销量 出现大幅增长,全年共实现销量61279吨,同比增长20.90%。 预计2004 年公司各系列产品将继续保持较高增长速度,尤其保健酒和香槟酒的销量增 幅将达到60%～70%左右。公司最近一个时期再融资的可能性不大,加之04年年底以前能完成国有股转让,并且公司有MBO 这一大背景,所以我们重申公司的中长期投资价值,建议增持。
After the company straightened out the marketing system in 2003, there was a substantial increase in sales of various series of alcoholic beverages. In the whole year, it achieved sales of 61,279 tons, a year-on-year increase of 20.90%. It is expected that each series of products of the company will continue to maintain a relatively high growth rate in 2004. In particular, sales of health wine and champagne will increase by about 60% to 70%. It is unlikely that the company will refinance in the most recent period. In addition, the transfer of state-owned shares can be completed before the end of 2004, and the company has the MBO background. Therefore, we reiterate the company’s mid-to-long-term investment value and propose to increase its holdings.